These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 24802942)
1. Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis. He XF; Liu LR; Wei W; Liu Y; Su J; Wang SL; Shen XL; Yang XB PLoS One; 2014; 9(5):e88490. PubMed ID: 24802942 [TBL] [Abstract][Full Text] [Related]
2. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Ding DP; He XF; Zhang Y Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776 [TBL] [Abstract][Full Text] [Related]
3. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis. Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016 [TBL] [Abstract][Full Text] [Related]
4. Association between the XPG gene Asp1104His polymorphism and lung cancer risk. Zhou B; Hu XM; Wu GY Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323149 [TBL] [Abstract][Full Text] [Related]
5. Modulation of DNA damage by XPF, XPG and ERCC1 gene polymorphisms in pesticide-exposed agricultural workers of Punjab, North-West India. Kaur K; Kaur R Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503302. PubMed ID: 33551103 [TBL] [Abstract][Full Text] [Related]
6. Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk. Peng Q; Lao X; Li R; Qin X; Li S Breast Cancer Res Treat; 2013 Jun; 139(2):617-8. PubMed ID: 23619551 [No Abstract] [Full Text] [Related]
7. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis. Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874 [TBL] [Abstract][Full Text] [Related]
8. Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population. Du H; Zhang X; Du M; Guo N; Chen Z; Shu Y; Zhang Z; Wang M; Zhu L Sci Rep; 2014 Oct; 4():6700. PubMed ID: 25332048 [TBL] [Abstract][Full Text] [Related]
9. Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case-control studies. Xu Y; Jiao G; Wei L; Wang N; Xue Y; Lan J; Wang Y; Liu C; Lou M Mol Genet Genomics; 2015 Feb; 290(1):273-9. PubMed ID: 25231183 [TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk. Liu C; Yin Q; Hu J; Weng J; Wang Y Tumour Biol; 2014 Feb; 35(2):1203-9. PubMed ID: 24061640 [TBL] [Abstract][Full Text] [Related]
11. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. Zhu ML; Wang M; Cao ZG; He J; Shi TY; Xia KQ; Qiu LX; Wei QY PLoS One; 2012; 7(7):e36293. PubMed ID: 22815677 [TBL] [Abstract][Full Text] [Related]
12. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population. Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634 [TBL] [Abstract][Full Text] [Related]
13. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy. Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216 [TBL] [Abstract][Full Text] [Related]
14. XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies. Xiang T; Kang X; Gong Z; Bai W; Chen C; Zhang W Cancer Chemother Pharmacol; 2017 Apr; 79(4):791-800. PubMed ID: 28314991 [TBL] [Abstract][Full Text] [Related]
15. XPG Asp1104His polymorphism and gastrointestinal cancers risk: a meta-analysis. Luo JF; Yan RC; Zou L Int J Clin Exp Med; 2014; 7(11):4174-82. PubMed ID: 25550928 [TBL] [Abstract][Full Text] [Related]
16. The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. Adolf IC; Rweyemamu LP; Akan G; Mselle TF; Dharsee N; Namkinga LA; Lyantagaye SL; Atalar F Cancer Med; 2023 Jan; 12(1):472-487. PubMed ID: 35691022 [TBL] [Abstract][Full Text] [Related]
17. Association of xeroderma pigmentosum complementation group G Asp1104His polymorphism with breast cancer risk: A cumulative meta-analysis. Xu XM; Xie LC; Yuan LL; Hu XL; Jin JQ; Niu YM Mol Clin Oncol; 2014 Nov; 2(6):1177-1181. PubMed ID: 25279219 [TBL] [Abstract][Full Text] [Related]
18. Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population. Chen YZ; Guo F; Sun HW; Kong HR; Dai SJ; Huang SH; Zhu WW; Yang WJ; Zhou MT J Cell Mol Med; 2016 May; 20(5):903-8. PubMed ID: 26820236 [TBL] [Abstract][Full Text] [Related]
19. Association of polymorphisms in nucleotide excision repair pathway genes with susceptibility to cutaneous melanoma. Hashemzehi A; Ghadyani M; Asadian F; Dastgheib SA; Kargar S; Neamatzadeh H; Akbarian E; Emarati A Klin Onkol; 2021; 34(5):350-355. PubMed ID: 34702042 [TBL] [Abstract][Full Text] [Related]
20. XPG Asp1104His, XRCC2 Rs3218536 A/G and RAD51 135G/C Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis. Eskandari E; Rezaifar A; Hashemi M Asian Pac J Cancer Prev; 2017 Jul; 18(7):1805-1813. PubMed ID: 28749109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]